Anand Rohatgi, MD

Anand Rohatgi

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: CSL Behring (MODEST), Horizon Therapeutics(MODEST), Raydel(MODEST), JP Morgan(MODEST), Johnson & Johnson(MODEST) RESEARCH/RESEARCH GRANTS: Quest(NONE), CSL Behring (NONE)

View Full Disclosure